药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
19-Nor-4-androstenedione
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Bilastine.
19-Nor-4-androstenedione
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Bilastine.
19-Nor-4-androstenedione
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Bilastine.
19-Nor-4-androstenedione
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Bilastine.
19-Nor-4-androstenedione
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Bilastine.
19-Nor-4-androstenedione
Pitolisant
The therapeutic efficacy of Pitolisant can be decreased when used in combination with Bilastine.
19-Nor-4-androstenedione
Delamanid
Bilastine may increase the QTc-prolonging activities of Delamanid.
19-Nor-4-androstenedione
Terodiline
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Terodiline.
19-Nor-4-androstenedione
Macimorelin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Macimorelin.
19-Nor-4-androstenedione
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Deutetrabenazine.
19-Nor-4-androstenedione
Glasdegib
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Glasdegib.
19-Nor-4-androstenedione
Ribociclib
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ribociclib.
19-Nor-4-androstenedione
Ivabradine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ivabradine.
19-Nor-4-androstenedione
Lumefantrine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Lumefantrine.
19-Nor-4-androstenedione
Artemether
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Artemether.
19-Nor-4-androstenedione
Asenapine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Asenapine.
19-Nor-4-androstenedione
Iloperidone
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Iloperidone.
19-Nor-4-androstenedione
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Tetrabenazine.
19-Nor-4-androstenedione
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Zuclopenthixol.
19-Nor-4-androstenedione
Berotralstat
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Berotralstat.